Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON-injection for a sooner and better treatment of cluster headache
2018-002224-17Phase 3Active
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cluster Headache (CH) comparing GON steroid injection + verapamil with Control (placebo/sham injection) + verapamil (2 arms). Primary endpoint: Decrease in mean total dose of verapamil used per day. Started Dec 2018; status: active.
02
Drugs
methylprednisolone
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2018-002224-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002224-17.